Myriad Genetics, Inc. (NAS: MYGN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

MYGNMyriad Genetics, Inc.

NAS · US · Healthcare · Diagnostics & Research · myriad.com

6.190USD-1.90%Mkt Cap: 584.63M $P/E: —1d ago

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap584.63M $

Enterprise Value433.93M $

Revenue (TTM)557.00M $

Gross Profit576.60M $

Net Income (TTM)-365.90M $

Revenue/Share7.452 USD

Last Price6.190 USD

Fiscal Year EndDec 2025

MR QuarterDec 2020

Employees2.7K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS62855J1043

Valuation

P/E (Trailing)—

P/E (Forward)40.96

PEG1.24

EV/EBITDA-3.88

EV/Revenue0.78

P/S1.05

P/B1.73

EPS (TTM)-4.31

EPS (Forward)0.15

52W Range

3.53053% of range8.590

52W High8.590 USD

52W Low3.530 USD

Profitability

Gross Margin69.93%

Oper. Margin-21.41%

EBITDA Margin-20.09%

Profit Margin-44.38%

ROE-99.43%

ROA-51.78%

Growth

Revenue Growth-20.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.80M $

CapEx (TTM)27.40M $

FCF Margin-8.27%

FCF Yield-7.88%

Net Debt-150.70M $

Net Debt/EBITDA1.35

Balance Sheet

Debt/Equity0.57

Current Ratio2.67

Quick Ratio1.65

Book Value/Sh3.574 USD

Cash/Share1.596 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateMar 26, 2009

Analyst Consensus

Rating3.0 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)6.250 USD

Upside (mean)+1.0%

Target Range4.000 USD – 10.00 USD

$4.000+1.0% to mean$10.00

# Analysts8

Ownership

Shares Out.94.45M

Float85.99M

Insiders3.76%

Institutions95.77%

Short Interest

Short Ratio4.9d

Short % Float9.30%

Short % Out.9.07%

Shares Short8.56M

Short (prev mo.)8.55M

Technical

SMA 504.711 (+31.4%)

SMA 2005.727 (+8.1%)

Beta1.64

S&P 52W Chg20.25%

Avg Vol (30d)1.40M

Avg Vol (10d)1.11M

Technical Indicators

RSI (14)67.0

MACD0.4299

MACD Signal0.4054

MACD Hist.+0.0245

BB Upper6.891 USD

BB Middle5.530 USD

BB Lower4.169 USD

BB Width49.21%

ATR (14)0.3326 USD

Vol Ratio (20d)0.66x